Reuters Health Report

On your mobile? Click here to view this email in text.
If you are having trouble viewing this email or would like to view it in your web browser, CLICK HERE
Reuters

Good evening Srini, THU 11 Dec 2008 

today's headlines

States cutting healthcare, report shows
About 40 pct of docs use electronic records: CDC
U.S. Amish gene trait may inspire heart protection
Glaxo, Novartis drug combo delays breast cancer
FDA panel says two asthma drugs risky
U.S. teen marijuana use decline faltering: survey
FDA advisory panel backs new female condom
Pfizer drug fails to beat tamoxifen at 2.75 years
Mentally ill drug abusers have more ER visits
High heart rates linked to obesity, diabetes: study
 

more details

States cutting healthcare, report shows
December 11, 2008 01:35 PM ET
WASHINGTON (Reuters) - Several U.S. states are cutting their health insurance coverage for residents, including the Medicaid program for the poor, because of budget deficits, according to a report released on Thursday.

Full Article
About 40 pct of docs use electronic records: CDC
December 11, 2008 03:00 PM ET
WASHINGTON (Reuters) - Just under than 40 percent of U.S. doctors use electronic medical records and many say the system they use is only minimally functional, according to federal survey results released on Thursday.

Full Article
U.S. Amish gene trait may inspire heart protection
December 11, 2008 03:39 PM ET
WASHINGTON (Reuters) - A rare genetic abnormality found in people in an insular Amish community protects them from heart disease, a discovery that could lead to new drugs to prevent heart ailments, U.S. researchers said on Thursday.

Full Article
Glaxo, Novartis drug combo delays breast cancer
December 11, 2008 05:34 PM ET
LONDON (Reuters) - Combining GlaxoSmithKline's Tykerb drug with Novartis's Femara can delay significantly the progression of breast cancer in some women, researchers said on Thursday.

Full Article
FDA panel says two asthma drugs risky
December 11, 2008 05:25 PM ET
ROCKVILLE, Maryland (Reuters) - Two asthma drugs, GlaxoSmithKline PLC's Serevent and Novartis AG's Foradil, pose serious risks that outweigh their benefits for treating adults, adolescents and children, a U.S. advisory panel ruled on Thursday.

Full Article
U.S. teen marijuana use decline faltering: survey
December 11, 2008 01:31 PM ET
WASHINGTON (Reuters) - Recent declines in marijuana use by U.S. teens appear to have stalled this year and their abuse of prescription drugs remains at worrisome levels, researchers said on Thursday.

Full Article
FDA advisory panel backs new female condom
December 11, 2008 05:22 PM ET
GAITHERSBURG, Maryland (Reuters) - Female Health Co's new, potentially less costly version of its female condom, won crucial backing from a U.S. Food and Drug Administration advisory panel on Thursday.

Full Article
Pfizer drug fails to beat tamoxifen at 2.75 years
December 11, 2008 05:37 PM ET
NEW YORK (Reuters) - Pfizer Inc said on Thursday its Aromasin cancer drug was no better than tamoxifen at achieving disease-free survival after 2.75 years among postmenopausal women with hormone-sensitive early breast cancer.

Full Article
Mentally ill drug abusers have more ER visits
December 11, 2008 05:36 PM ET
NEW YORK (Reuters Health) - Drug abusers with mental illness visit emergency rooms more often than their counterparts without mental illness, according to a study published in BMC Emergency Medicine.

Full Article
High heart rates linked to obesity, diabetes: study
December 11, 2008 02:12 PM ET
HONG KONG (Reuters) - High resting heart rates may be linked to the development of obesity and diabetes, a Japanese study shows.

Full Article
 
 


Reuters.com.









REUTERS www.reuters.com
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book.Details
Subscribe to other Reuters newsletters
Unsubscribe from this newsletter.


Forward to a friend Send this mailing to a friend or colleague

Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS RSS Feed | Interactive TV | Labs | Reuters in Second Life | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

 

0 comments: